[DOI] [PMC free article] [PubMed] [Google Scholar] 100.Cole S., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., Deeley R.G
Three non-selective serotonin-receptor agonists were approved by FDA: fenfluramine (1973-1997), the combination phentermine-fenfluramine (1992-1997), and dexfenfluramine (1996-1997)
(1) Limit of detection (LOD) was calculated according to the following standard Eqs
The safety and antiaging effects of nicotinamide mononucleotide in human clinical trials: an update
This innovative liposomal delivery system ensures that the bioavailability of glutathione is maximized, allowing for more effective results compared to standard glutathione supplements
Antioxidants (2022) 11:154